These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 24747946)

  • 1. Normal appearing and diffusely abnormal white matter in patients with multiple sclerosis assessed with quantitative MR.
    West J; Aalto A; Tisell A; Leinhard OD; Landtblom AM; Smedby Ö; Lundberg P
    PLoS One; 2014; 9(4):e95161. PubMed ID: 24747946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffusely appearing white matter in multiple sclerosis: Insights from sodium (
    Weber CE; Nagel K; Ebert A; Roßmanith C; Paschke N; Adlung A; Platten M; Schad LR; Gass A; Eisele P
    Mult Scler Relat Disord; 2021 Apr; 49():102752. PubMed ID: 33486402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automated separation of diffusely abnormal white matter from focal white matter lesions on MRI in multiple sclerosis.
    Maranzano J; Dadar M; Zhernovaia M; Arnold DL; Collins DL; Narayanan S
    Neuroimage; 2020 Jun; 213():116690. PubMed ID: 32119987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T2 Relaxometry Evidence of Microstructural Changes in Diffusely Abnormal White Matter in Relapsing-Remitting Multiple Sclerosis and Clinically Isolated Syndrome: Impact on Visuomotor Performance.
    Papadaki E; Mastorodemos V; Panou T; Pouli S; Spyridaki E; Kavroulakis E; Kalaitzakis G; Maris TG; Simos P
    J Magn Reson Imaging; 2021 Oct; 54(4):1077-1087. PubMed ID: 33960066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative assessment of myelin-sensitive measures in multiple sclerosis patients and healthy subjects.
    Rahmanzadeh R; Weigel M; Lu PJ; Melie-Garcia L; Nguyen TD; Cagol A; La Rosa F; Barakovic M; Lutti A; Wang Y; Bach Cuadra M; Radue EW; Gaetano L; Kappos L; Kuhle J; Magon S; Granziera C
    Neuroimage Clin; 2022; 36():103177. PubMed ID: 36067611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative texture analysis of brain white matter lesions derived from T2-weighted MR images in MS patients with clinically isolated syndrome.
    Loizou CP; Petroudi S; Seimenis I; Pantziaris M; Pattichis CS
    J Neuroradiol; 2015 Apr; 42(2):99-114. PubMed ID: 24970463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased concentrations of glutamate and glutamine in normal-appearing white matter of patients with multiple sclerosis and normal MR imaging brain scans.
    Tisell A; Leinhard OD; Warntjes JB; Aalto A; Smedby Ö; Landtblom AM; Lundberg P
    PLoS One; 2013; 8(4):e61817. PubMed ID: 23613944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusely abnormal white matter in multiple sclerosis.
    Cairns J; Vavasour IM; Traboulsee A; Carruthers R; Kolind SH; Li DKB; Moore GRW; Laule C
    J Neuroimaging; 2022 Jan; 32(1):5-16. PubMed ID: 34752664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusely abnormal white matter in chronic multiple sclerosis: imaging and histopathologic analysis.
    Seewann A; Vrenken H; van der Valk P; Blezer EL; Knol DL; Castelijns JA; Polman CH; Pouwels PJ; Barkhof F; Geurts JJ
    Arch Neurol; 2009 May; 66(5):601-9. PubMed ID: 19433660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusely abnormal white matter in progressive multiple sclerosis: in vivo quantitative MR imaging characterization and comparison between disease types.
    Vrenken H; Seewann A; Knol DL; Polman CH; Barkhof F; Geurts JJ
    AJNR Am J Neuroradiol; 2010 Mar; 31(3):541-8. PubMed ID: 19850760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between retinal nerve fibre layer thickness and N-acetyl aspartate levels in multiple sclerosis brain normal-appearing white matter: a longitudinal study using magnetic resonance spectroscopy and optical coherence tomography.
    Pardini M; Botzkowski D; Müller S; Vehoff J; Kuhle J; Ruberte E; Würfel J; Gass A; Valmaggia C; Tettenborn B; Putzki N; Yaldizli Ö
    Eur J Neurol; 2016 Dec; 23(12):1769-1774. PubMed ID: 27591406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-parametric quantitative MRI of normal appearing white matter in multiple sclerosis, and the effect of disease activity on T2.
    Reitz SC; Hof SM; Fleischer V; Brodski A; Gröger A; Gracien RM; Droby A; Steinmetz H; Ziemann U; Zipp F; Deichmann R; Klein JC
    Brain Imaging Behav; 2017 Jun; 11(3):744-753. PubMed ID: 27138529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extensive Brain Pathologic Alterations Detected with 7.0-T MR Spectroscopic Imaging Associated with Disability in Multiple Sclerosis.
    Heckova E; Dal-Bianco A; Strasser B; Hangel GJ; Lipka A; Motyka S; Hingerl L; Rommer PS; Berger T; Hnilicová P; Kantorová E; Leutmezer F; Kurča E; Gruber S; Trattnig S; Bogner W
    Radiology; 2022 Apr; 303(1):141-150. PubMed ID: 34981978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dirty-appearing white matter in multiple sclerosis: volumetric MR imaging and magnetization transfer ratio histogram analysis.
    Ge Y; Grossman RI; Babb JS; He J; Mannon LJ
    AJNR Am J Neuroradiol; 2003; 24(10):1935-40. PubMed ID: 14625213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantifying the Susceptibility Variation of Normal-Appearing White Matter in Multiple Sclerosis by Quantitative Susceptibility Mapping.
    Chen W; Zhang Y; Mu K; Pan C; Gauthier SA; Zhu W; Wang Y
    AJR Am J Roentgenol; 2017 Oct; 209(4):889-894. PubMed ID: 28705068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative susceptibility mapping of the normal-appearing white matter as a potential new marker of disability progression in multiple sclerosis.
    Pietroboni AM; Colombi A; Contarino VE; Russo FML; Conte G; Morabito A; Siggillino S; Carandini T; Fenoglio C; Arighi A; De Riz MA; Arcaro M; Sacchi L; Fumagalli GG; Bianchi AM; Triulzi F; Scarpini E; Galimberti D
    Eur Radiol; 2023 Aug; 33(8):5368-5377. PubMed ID: 36562783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiparameter MRI quantification of microstructural tissue alterations in multiple sclerosis.
    Lommers E; Simon J; Reuter G; Delrue G; Dive D; Degueldre C; Balteau E; Phillips C; Maquet P
    Neuroimage Clin; 2019; 23():101879. PubMed ID: 31176293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficient MWF mapping in multiple sclerosis using 3D whole-brain multi-component relaxation MRI.
    Kitzler HH; Su J; Zeineh M; Harper-Little C; Leung A; Kremenchutzky M; Deoni SC; Rutt BK
    Neuroimage; 2012 Feb; 59(3):2670-7. PubMed ID: 21920444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A quantitative evaluation of damage in normal appearing white matter in patients with multiple sclerosis using diffusion tensor MR imaging at 3 T.
    Gratsias G; Kapsalaki E; Kogia S; Dardiotis E; Tsimourtou V; Lavdas E; Kousi E; Pelekanou A; Hadjigeorgiou GM; Fezoulidis I
    Acta Neurol Belg; 2015 Jun; 115(2):111-6. PubMed ID: 25073775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathological correlates of magnetic resonance imaging texture heterogeneity in multiple sclerosis.
    Zhang Y; Moore GR; Laule C; Bjarnason TA; Kozlowski P; Traboulsee A; Li DK
    Ann Neurol; 2013 Jul; 74(1):91-9. PubMed ID: 23939554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.